Dear Patient,

Pharmacovigilance serves the legally anchored effort to make approved medicinal products even safer for you. A. Menarini Pharma GmbH is also committed to this goal.

Patients have the opportunity to report suspected adverse drug reactions to the Federal Office for Safety in Health Care (BASG) via the Internet portal for medicinal products or by mail.

To get to the correct page of the BASG, please click on this link address:

(Suspected) adverse reactions can be reported at:

You can also report (suspected) adverse reactions to medicines from A. Menarini Pharma LLC directly to us at:


E-Mail: pv[at]menarini[dot]at

Tel.: 01 / 879 95 85 - 0 (please follow the instructions)
Fax: 01 / 879 95 85 - 60

Your report should contain information about you as a patient, about the corresponding product of A. Menarini Pharma GmbH and about the adverse reaction. You can find our privacy policy here.


Dear visitor, the gender form selected on our homepage always refers to female, male and various people at the same time. We have refrained from using a gender-specific spelling or multiple designations solely for the purpose of better readability. All personal designations are to be understood as gender-neutral.

Liebe Besucherin, lieber Besucher, die auf unserer Homepage gewählte Geschlechtsform bezieht sich immer zugleich auf weibliche, männliche und diverse Personen. Wir haben ausschließlich zum Zweck der besseren Lesbarkeit auf eine geschlechtsspezifische Schreibweise bzw. auf eine Mehrfachbezeichnung verzichtet. Alle personenbezogenen Bezeichnungen sind geschlechtsneutral zu verstehen.